Human Phenotype Ontology 
Grandparent Node:
expand
Growth abnormality (HP:0001507)help
Parent Node:
expand
Abnormality of limbs (HP:0040064)help
Parent Node:
expand
Asymmetric growth (HP:0100555)help
..Starting node
..expand
Hemihypertrophy (HP:0001528)help
Term ID: 1528
Name: Hemihypertrophy
Synonym: Asymmetric limb hypertrophy; Asymmetric overgrowth
Definition: Overgrowth of only one side of the body.
Comments:
Reference: HP:0001528
Genes and Diseases:
 
       Child Nodes:
........expandHemihypertrophy of lower limb (HP:0100553) help
........expandHemihypertrophy of upper limb (HP:0100554) help

 Sister Nodes: 
..expandHemiatrophy (HP:0100556) help
..expandLower limb asymmetry (HP:0100559) help
..expandUpper limb asymmetry (HP:0100560) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0001528HP:0001528Hemihypertrophy0AKT1 CL E G H207391OMIM:176920Proteus syndrome, somatic.54
HP:0001528HP:0001528Hemihypertrophy0AKT2 CL E G H208392ORPHA:293964Hypoinsulinemic hypoglycemia and body hemihypertrophyHP:0040280 - Obligate12
HP:0001528HP:0001528Hemihypertrophy0AKT2 CL E G H208392OMIM:240900Hypoinsulinemic hypoglycemia with hemihypertrophy.12
HP:0001528HP:0001528Hemihypertrophy0CDKN1C CL E G H10281786OMIM:130650Beckwith-Wiedemann syndrome.114
HP:0001528HP:0001528Hemihypertrophy0DNMT3A CL E G H17882978OMIM:615879Tatton-Brown-Rahman syndrome44
HP:0001528HP:0001528Hemihypertrophy0H19 CL E G H2831204713ORPHA:2128Isolated hemihyperplasiaHP:0040281 - Very frequent4
HP:0001528HP:0001528Hemihypertrophy0H19-ICR CL E G H105259599OMIM:130650Beckwith-Wiedemann syndrome.
HP:0001528HP:0001528Hemihypertrophy0HNF1B CL E G H692811630ORPHA:1309Medullary sponge kidneyHP:0040283 - Occasional90
HP:0001528HP:0001528Hemihypertrophy0HRAS CL E G H32655173ORPHA:2874Phakomatosis pigmentokeratotica113
HP:0001528HP:0001528Hemihypertrophy0HRAS CL E G H32655173OMIM:163200Schimmelpenning-Feuerstein-Mims syndrome.113
HP:0001528HP:0001528Hemihypertrophy0IGF2 CL E G H34815466OMIM:130650Beckwith-Wiedemann syndrome.9
HP:0001528HP:0001528Hemihypertrophy0IGF2 CL E G H34815466ORPHA:2128Isolated hemihyperplasiaHP:0040281 - Very frequent9
HP:0001528HP:0001528Hemihypertrophy0KCNQ1 CL E G H37846294OMIM:130650Beckwith-Wiedemann syndrome.730
HP:0001528HP:0001528Hemihypertrophy0KCNQ1OT1 CL E G H109846295OMIM:130650Beckwith-Wiedemann syndrome.1
HP:0001528HP:0001528Hemihypertrophy0KCNQ1OT1 CL E G H109846295ORPHA:2128Isolated hemihyperplasiaHP:0040281 - Very frequent1
HP:0001528HP:0001528Hemihypertrophy0KRAS CL E G H38456407OMIM:163200Schimmelpenning-Feuerstein-Mims syndrome.196
HP:0001528HP:0001528Hemihypertrophy0NRAS CL E G H48937989OMIM:163200Schimmelpenning-Feuerstein-Mims syndrome.102
HP:0001528HP:0001528Hemihypertrophy0PIK3CA CL E G H52908975OMIM:613089Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowthHP:0040284 - Very rare162
HP:0001528HP:0001528Hemihypertrophy0PIK3CA CL E G H52908975OMIM:612918Congenital lipomatous overgrowth, vascular malformations, and epidermal neviHP:0040280 - Obligate162
HP:0001528HP:0001528Hemihypertrophy0RASA1 CL E G H59219871ORPHA:90307Parkes Weber syndrome88
HP:0001528HP:0001528Hemihypertrophy0RNF125 CL E G H5494121150OMIM:616260Tenorio syndrome.5
HP:0001528HP:0001528Hemihypertrophy0ZNF699 CL E G H37487924750OMIM:619488DEGCAGS SYNDROME; DEGCAGS
HP:0001528HP:0100554Hemihypertrophy of upper limb1 CL E G H
HP:0001528HP:0100553Hemihypertrophy of lower limb1RASA1 CL E G H59219871ORPHA:90307Parkes Weber syndromeHP:0040282 - Frequent88


Genes (17) :AKT1 AKT2 CDKN1C DNMT3A H19 H19-ICR HNF1B HRAS IGF2 KCNQ1 KCNQ1OT1 KRAS NRAS PIK3CA RASA1 RNF125 ZNF699

Diseases (14) :OMIM:176920 ORPHA:293964 OMIM:240900 OMIM:130650 OMIM:615879 ORPHA:2128 ORPHA:1309 ORPHA:2874 OMIM:163200 OMIM:613089 OMIM:612918 ORPHA:90307 OMIM:616260 OMIM:619488
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.